While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...
Shares of GSK PLC GSK inched down 0.51% to £13.57 Friday, on what proved to be an all-around poor trading session for the ...
The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...
Ballentine Partners LLC boosted its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 40.7% in the fourth quarter, ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
PharmaCord Founder and CEO Nitin Sahney will continue to serve on the Board of Directors and remains a significant investor in the Company. Since founding PharmaCord in 2017, Sahney has led the ...
“We are pleased to welcome Reena to Applied and are confident that her wealth of experience as a leader across quality functions will support our mission of meeting the unmet needs of patients with ...
MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...